FIBROSpect® NASH
Use
PROMETHEUS FIBROSpect® NASH is a laboratory-developed test that aids in the detection, staging, and monitoring of liver fibrosis in nonalcoholic steatohepatitis patients. It provides a quantitative fibrosis score to help physicians risk stratify and monitor patients using three clinically relevant biomarkers, potentially reducing the need for biopsy.
Special Instructions
The test is noninvasive, does not require fasting, and can be repeated frequently. Proprietary algorithm differentiates F0-F2 from F3-F4 fibrosis stages. Validated with biopsy-confirmed samples.
Limitations
FIBROSpect® NASH has been validated with biopsy-confirmed NASH patient samples under specific conditions. It may not detect all stages of liver fibrosis or replace biopsy completely. Variability in results may occur due to different patient conditions.
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
Result Turnaround Time
7 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2.0 mL
Minimum Volume
0.5 mL for Peds
Container
Serum Separator Tube or Red-Top Tube
Storage Instructions
Ambient or cold pack. Do not freeze.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 30 days |